FY2025 EPS Estimate for Aurora Cannabis Boosted by Analyst

Aurora Cannabis Inc. (NASDAQ:ACB) – Equities researchers at Atb Cap Markets increased their FY2025 earnings estimates for Aurora Cannabis in a note issued to investors on Wednesday, February 5th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of $0.46 for the year, up from their prior estimate of ($0.10). Atb Cap Markets has a “Strong-Buy” rating on the stock. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.10) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.06) EPS, FY2026 earnings at $0.00 EPS, FY2027 earnings at $0.17 EPS, FY2028 earnings at $0.37 EPS and FY2029 earnings at $0.61 EPS.

Aurora Cannabis (NASDAQ:ACB) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a net margin of 0.42% and a return on equity of 0.59%.

A number of other equities analysts have also recently commented on ACB. TD Cowen assumed coverage on shares of Aurora Cannabis in a report on Wednesday, December 11th. They issued a “buy” rating on the stock. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th.

Aurora Cannabis Trading Down 2.9 %

ACB opened at $6.42 on Monday. The company has a quick ratio of 1.88, a current ratio of 3.30 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The business’s 50 day moving average is $4.35 and its two-hundred day moving average is $5.16. The firm has a market cap of $352.20 million, a price-to-earnings ratio of 128.43 and a beta of 1.84.

Hedge Funds Weigh In On Aurora Cannabis

Several institutional investors have recently bought and sold shares of ACB. SBI Securities Co. Ltd. acquired a new position in shares of Aurora Cannabis during the fourth quarter worth about $31,000. Cubist Systematic Strategies LLC acquired a new position in Aurora Cannabis during the 2nd quarter worth approximately $50,000. Wealthspire Advisors LLC purchased a new position in shares of Aurora Cannabis during the 4th quarter worth approximately $149,000. Finally, Tidal Investments LLC lifted its holdings in shares of Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after buying an additional 34,988 shares during the period. 47.63% of the stock is owned by institutional investors and hedge funds.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.